Replies to post #301038 on Anavex Life Sciences Corp (AVXL)

[falconer66a]

Will have to wait.

Since you are in speculation mode what are you expecting from the upcoming peer reviewed article?

Well, of course, I speculate that the PDD trial outcomes, in a peer-reviewed journal, will be exceedingly positive; will greatly facilitate or prompt FDA approval of blarcamesine for Parkinson's disease dementia. I'm really eager to see if blarcamesine improved restorative sleep in those patients. If so, gigantic for all CNS diseases involving poor sleep. It's in most of them; a major complicating disease factor.

But, the details will have to present themselves in the paper. Of course, I and several others, here, will present our interpretations of the data when they appear. But nothing to date, murine or human, suggests anything negative. Betting against that paper (as with Anavex in general) would be a high-risk proposition